Universidade Federal do Rio de Janeiro, Hospital Universitário, Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro, Hospital Universitário, Rio de Janeiro, RJ, Brazil.
Braz J Infect Dis. 2018 Nov-Dec;22(6):455-461. doi: 10.1016/j.bjid.2018.10.278. Epub 2018 Nov 20.
The impact of central venous catheter (CVC) removal on the outcome of patients with candidemia is controversial, with studies reporting discrepant results depending on the time of CVC removal (early or any time during the course of candidemia).
Evaluate the effect of time to CVC removal, early (within 48h from the diagnosis of candidemia) vs. removal at any time during the course of candidemia, on the 30-day mortality.
Retrospective cohort study of 285 patients with candidemia analyzing CVC removal within 48h (first analysis) or at any time (second analysis).
A CVC was in place in 212 patients and was removed in 148 (69.8%), either early (88 patients, 41.5%) or late (60 patients, 28.3%). Overall, the median time to CVC removal was one day (range 1-28) but was six days (range 3-28) for those removed later. In the first analysis, APACHE II score (odds ratio [OR] 1.111, 95% confidence interval [95% CI] 1.066-1.158), removal at any time (OR 0.079, 95% CI 0.021-0.298) and Candida parapsilosis infection (OR 0.291, 95% CI 0.133-0.638) were predictors of 30-day mortality. Early removal was not significant. In the second analysis APACHE II score (OR 1.122, 95% CI 1.071-1.175) and C. parapsilosis infection (OR 0.247, 95% CI 0.103-0.590) retained significance.
The impact of CVC removal is dependent on whether the optimal analysis strategy is deployed and should be taken into consideration in future analyses.
中心静脉导管(CVC)拔除对念珠菌血症患者结局的影响存在争议,不同研究根据念珠菌血症发生时 CVC 拔除的时间(早期或念珠菌血症发生期间的任何时间)报告了不一致的结果。
评估 CVC 拔除时间(念珠菌血症诊断后 48 小时内 vs. 念珠菌血症发生期间的任何时间)对 30 天死亡率的影响。
对 285 例念珠菌血症患者进行回顾性队列研究,分析 CVC 在 48 小时内(第一次分析)或任何时间(第二次分析)拔除的情况。
212 例患者存在 CVC,148 例(69.8%)拔除了 CVC,其中 88 例(41.5%)为早期拔除,60 例(28.3%)为晚期拔除。总体而言,CVC 拔除的中位时间为 1 天(范围 1-28),但晚期拔除的时间为 6 天(范围 3-28)。在第一次分析中,APACHE II 评分(比值比 [OR] 1.111,95%置信区间 [95%CI] 1.066-1.158)、任何时间拔除(OR 0.079,95%CI 0.021-0.298)和近平滑念珠菌感染(OR 0.291,95%CI 0.133-0.638)是 30 天死亡率的预测因素。早期拔除没有显著意义。在第二次分析中,APACHE II 评分(OR 1.122,95%CI 1.071-1.175)和近平滑念珠菌感染(OR 0.247,95%CI 0.103-0.590)仍然具有显著意义。
CVC 拔除的影响取决于是否采用了最佳分析策略,未来的分析应考虑这一点。